Clinical Trial Update: Evaluate the Pharmacokinetics of Quetiapine Fumarate in Chinese Schizophrenic Patients [Phase 1]

View source ↗

Summary

A completed Phase 1 pharmacokinetics study evaluating quetiapine fumarate in Chinese patients with schizophrenia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Drugs mentioned

• Quetiapine fumarate (Quetiapine fumarate)

Snippet

Sponsor: AstraZeneca | Conditions: Schizophrenia | Phase 1 | Status: COMPLETED